v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2024   42,848,339      
Beginning balance at Dec. 31, 2024 $ 1,810,882 $ 428 $ 491,891 $ 1,401,034 $ (82,471)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income 46,984     46,984  
Other comprehensive income (loss), net of tax 23,697       23,697
Issuance (Forfeitures) of restricted stock, net (in shares)   165,479      
Issuance (Forfeitures) of restricted stock, net (4,452) $ 3 (8,110) 3,655  
Issuance of shares under employee stock purchase plan (in shares)   133,956      
Issuance of shares under employee stock purchase plan 3,750 $ 1 3,749    
Repurchase and retirement of common stock (in shares) [1]   (3,154,566)      
Repurchase and retirement of common stock [1] (115,454) $ (32) (38,457) (76,965)  
Share-based compensation 33,591   33,591    
Sale of Connectivity 0        
Other, net (89)   3 (92)  
Ending balance (in shares) at Sep. 30, 2025   39,993,208      
Ending balance at Sep. 30, 2025 1,798,909 $ 400 482,667 1,374,616 (58,774)
Beginning balance (in shares) at Jun. 30, 2025   41,168,057      
Beginning balance at Jun. 30, 2025 1,842,659 $ 412 484,498 1,409,468 (51,719)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (3,598)     (3,598)  
Other comprehensive income (loss), net of tax (7,055)       (7,055)
Issuance (Forfeitures) of restricted stock, net (in shares)   1,710      
Issuance (Forfeitures) of restricted stock, net (29)   (62) 33  
Repurchase and retirement of common stock (in shares)   (1,176,559)      
Repurchase and retirement of common stock (44,882) $ (12) (13,874) (30,996)  
Share-based compensation 12,111   12,111    
Sale of Connectivity 0        
Other, net (297)   (6) (291)  
Ending balance (in shares) at Sep. 30, 2025   39,993,208      
Ending balance at Sep. 30, 2025 $ 1,798,909 $ 400 482,667 1,374,616 (58,774)
Beginning balance (in shares) at Dec. 31, 2025 38,376,859 38,376,859      
Beginning balance at Dec. 31, 2025 $ 1,753,575 $ 384 472,723 1,337,542 (57,074)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income 618,030     618,030  
Other comprehensive income (loss), net of tax (9,522)       (9,522)
Issuance (Forfeitures) of restricted stock, net (in shares)   102,943      
Issuance (Forfeitures) of restricted stock, net (7,116) $ 1 (11,457) 4,340  
Issuance of shares under employee stock purchase plan (in shares)   137,218      
Issuance of shares under employee stock purchase plan 3,477 $ 1 3,476    
Repurchase and retirement of common stock (in shares)   (5,514,740)      
Repurchase and retirement of common stock (260,504) $ (55) (68,640) (191,809)  
Share-based compensation 33,536   33,536    
Sale of Connectivity (1,227)       (1,227)
Other, net [2] $ (1,110)   (2,136) 1,026  
Ending balance (in shares) at Sep. 30, 2026 33,102,280 33,102,280      
Ending balance at Sep. 30, 2026 $ 2,129,139 $ 331 427,502 1,769,129 (67,823)
Beginning balance (in shares) at Jun. 30, 2026   34,962,853      
Beginning balance at Jun. 30, 2026 2,237,458 $ 350 436,450 1,867,704 (67,046)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (28,692)     (28,692)  
Other comprehensive income (loss), net of tax (777)       (777)
Issuance (Forfeitures) of restricted stock, net (in shares)   (159,706)      
Issuance (Forfeitures) of restricted stock, net (104) $ 2 (76) (26)  
Repurchase and retirement of common stock (in shares)   (1,700,867)      
Repurchase and retirement of common stock (91,887) $ (17) (21,622) (70,248)  
Share-based compensation 12,757   12,757    
Sale of Connectivity 0        
Other, net $ 384   (7) 391  
Ending balance (in shares) at Sep. 30, 2026 33,102,280 33,102,280      
Ending balance at Sep. 30, 2026 $ 2,129,139 $ 331 $ 427,502 $ 1,769,129 $ (67,823)
[1] Includes 143,161 shares received in connection with sale of our minority equity ownership interest in OpenEvidence during the nine months ended September 30, 2025.
[2] Includes $1.8 million decrease in ‘Additional-paid-in-capital’ related to a change in classification of certain equity awards from equity-classified to liability-classified. Refer to Note 12 — Share-Based Compensation for additional details.